AU9144682A - 3-nitrophenyl quinazolines or pyrimidines - Google Patents

3-nitrophenyl quinazolines or pyrimidines

Info

Publication number
AU9144682A
AU9144682A AU91446/82A AU9144682A AU9144682A AU 9144682 A AU9144682 A AU 9144682A AU 91446/82 A AU91446/82 A AU 91446/82A AU 9144682 A AU9144682 A AU 9144682A AU 9144682 A AU9144682 A AU 9144682A
Authority
AU
Australia
Prior art keywords
denotes
quinazolines
pyrimidines
nitrophenyl
optionally
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU91446/82A
Inventor
Harald Horstmann
Bernhard Pelster
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Troponwerke GmbH
Original Assignee
Troponwerke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke GmbH filed Critical Troponwerke GmbH
Publication of AU9144682A publication Critical patent/AU9144682A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

1. Cutaneously administrable medicament containing a compound of the general formula see diagramm : EP0082385,P7,F1 in which R denotes hydrogen, optionally unsaturated lower alkyl or aralkyl with in each case 1 to 20 carbon atoms, X denotes oxygen or sulphur and Y denotes nitrogen or CH, in the form of suppositories, suspensions, emulsions, sprays, powders, gels, ointments, pastes, creams and solutions, optionally in a microencapsulated from, but with the exception of tragacanth salt solutions.
AU91446/82A 1981-12-18 1982-12-13 3-nitrophenyl quinazolines or pyrimidines Abandoned AU9144682A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19813150271 DE3150271A1 (en) 1981-12-18 1981-12-18 1- (3-NITROPHENYL) PYRIDO (2.3-D) PYRIMIDINE-2.4 (1H, 3H) -DIONE AND 1- (3-NITROPHENYL) CHINAZOLINE-2.4 (1H, 3H) -DIONE AS A CUTANE MEDICINAL PRODUCT
DE31502717 1981-12-18

Publications (1)

Publication Number Publication Date
AU9144682A true AU9144682A (en) 1983-06-23

Family

ID=6149136

Family Applications (1)

Application Number Title Priority Date Filing Date
AU91446/82A Abandoned AU9144682A (en) 1981-12-18 1982-12-13 3-nitrophenyl quinazolines or pyrimidines

Country Status (11)

Country Link
EP (1) EP0082385B1 (en)
JP (1) JPS58110518A (en)
AT (1) ATE21032T1 (en)
AU (1) AU9144682A (en)
CA (1) CA1201065A (en)
DE (2) DE3150271A1 (en)
FI (1) FI824330L (en)
GR (1) GR78419B (en)
NO (1) NO824044L (en)
PT (1) PT75957B (en)
ZA (1) ZA829268B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7064114B2 (en) 1999-03-19 2006-06-20 Parker Hughes Institute Gel-microemulsion formulations
JP2002539262A (en) * 1999-03-19 2002-11-19 パーカー ヒューズ インスティテュート Quinazoline compound formulations and their use in therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1491510A (en) * 1973-12-14 1977-11-09 Hisamitsu Pharmaceutical Co 1-nitrophenylquinazoline-2,4(1h,3h)-diones
JPS5649917B2 (en) * 1973-12-18 1981-11-25
DE3172006D1 (en) * 1980-05-22 1985-10-03 Masayuki Ishikawa Novel quinazoline-dione compounds, process for production thereof and pharmaceutical use thereof

Also Published As

Publication number Publication date
FI824330L (en) 1983-06-19
FI824330A0 (en) 1982-12-16
DE3272381D1 (en) 1986-09-04
GR78419B (en) 1984-09-27
EP0082385B1 (en) 1986-07-30
CA1201065A (en) 1986-02-25
NO824044L (en) 1983-06-20
DE3150271A1 (en) 1983-06-30
ATE21032T1 (en) 1986-08-15
JPS58110518A (en) 1983-07-01
PT75957B (en) 1985-10-04
PT75957A (en) 1983-01-01
ZA829268B (en) 1983-10-26
EP0082385A1 (en) 1983-06-29

Similar Documents

Publication Publication Date Title
EP0204529A3 (en) Anti-cancer quinazoline derivatives
HK1011998A1 (en) Antiretroviral enantiomeric nucleotide analogs
GB1232748A (en)
DE69111412T2 (en) Process for the selective flotation of metal ores with 2-mercaptothiazole derivatives.
DE3579004D1 (en) NEW SULFOBETAINE OF AMMONIOCARBONIC ACID AMIDES AND METHOD FOR THE PRODUCTION THEREOF.
DE3376653D1 (en) Therapeutically active di-, tri-, tetra- and penta-aza indenes
KR870006033A (en) Process for preparing pyridinyl pyrimidine derivative
AU9144682A (en) 3-nitrophenyl quinazolines or pyrimidines
KR850002460A (en) Process for preparing carbamate compound
GR78904B (en)
KR950003299A (en) Cephalosporin synthetic intermediate
IE780182L (en) N-9,10-DIHYDROLYSERGYL-m-AMINOBENZOIC ACID AMIDES.
KR850002979A (en) New Preparation Method of 1,2,3-Trithian Compound
ATE38829T1 (en) PHENYLBENZOYL UREAS.
ATE90356T1 (en) 21-ALKOXY-STEROID DERIVATIVES.
FR2494272B1 (en)
ES8303400A1 (en) Benzylazole derivatives.
ZA813653B (en) Hydrocarbon-soluble sodium alkyls
GR3000593T3 (en) Azaanthracene compounds
DE3667279D1 (en) 5-ISOXAZOLE CARBONIC ACID AMIDES, THEIR PRODUCTION AND USE AS FUNGICIDES.
ATE17847T1 (en) SALTS OF BIS-GUANIDIN COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MICROBICIDES.
GR78793B (en)
TH2442EX (en) Azole-tetrahydro-furan-2-illydine methane derivatives with different displacement groups.
DE3464598D1 (en) Acetylene derivatives having an enzyme-inhibiting activity, their preparation and their use as medicines
TH2442A (en) Azole-tetrahydro-furan-2-illydine methane derivatives with different displacement groups.